Decheng Capital Global Life Sciences Fund IV, L.P.

Holdings History for Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share

Investment type
Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Shares Owned
3,917,299 shares
Security Ownership %
18%

Xiangmin Cui ownership in Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share

24 Feb 2025 - Xiangmin Cui has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,917,299 shares of Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share. This represents 18% ownership of the company. This is the first filing by Decheng Capital Global Life Sciences Fund IV, L.P. disclosing ownership of Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share.